Adenovirus pneumonia mimicking osimertinib‐induced pneumonitis in a patient with advanced NSCLC with EGFR mutation: A case report by Toru Imai, Tatsuya Yoshida, Yuichiro Ohe

Get full text

Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report by Clara So, Tatsuya Yoshida, Takaaki Mizuno, Yasushi Yatabe, Yuichiro Ohe

Get full text

Co‐occurring KEAP1 and TP53 mutations in lung squamous cell carcinoma induced primary resistance to thoracic radiotherapy: A case report by Rumi Nishimura, Tatsuya Yoshida, Masahiro Torasawa, Tairo Kashihara, Yuichiro Ohe

Get full text

End‐of‐life impact of concurrent diabetes mellitus and adrenal insufficiency as immune‐related adverse events in an advanced non‐small cell lung cancer patient by Tomoaki Nakamura, Yuki Takeyasu, Tatsuya Yoshida, Ken Ohashi, Yuichiro Ohe

Get full text

The Development of a Skin Cancer Classification System for Pigmented Skin Lesions Using Deep Learning by Shunichi Jinnai, Naoya Yamazaki, Yuichiro Hirano, Yohei Sugawara, Yuichiro Ohe, Ryuji Hamamoto

Get full text

The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report by Kazushi Yoshida, Yutaka Fujiwara, Yasushi Goto, Takashi Kohno, Akihiko Yoshida, Koji Tsuta, Yuichiro Ohe

Get full text

Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual pa... by Yuri Taniguchi, Hiroaki Okamoto, Tsuneo Shimokawa, Tomonari Sasaki, Takashi Seto, Seiji Niho, Yuichiro Ohe, Yusuke Saigusa

Get full text

The Long Half-Life of Programmed Cell Death Protein 1 Inhibitors May Increase the Frequency of Immune-Related Adverse Events After Subsequent EGFR Tyrosine Kinase Inhibitor Therapy by Yuki Shinno, MD, Yasushi Goto, MD, PhD, Mayu Ohuchi, Akinobu Hamada, Hiroshi Nokihara, Yasuhiro Fujiwara, Yuichiro Ohe

Get full text

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease. by Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi, Takashi Kohno, Takuji Okusaka, Hideki Ueno, Kenji Tamura, Yuichiro Ohe, Hitoshi Zembutsu

Get full text

Mixed response to osimertinib and the beneficial effects of additional local therapy by Yuki Shinno, Yasushi Goto, Jun Sato, Ryo Morita, Yuji Matsumoto, Shuji Murakami, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

Get full text

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure by Takaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, Jun Sato, Ryo Morita, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

Get full text

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer by Ryota Shibaki, Shuji Murakami, Yuki Shinno, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noriko Motoi, Noboru Yamamoto, Yuichiro Ohe

Get full text

Predictive relevance of lymphovascular invasion in T1 colorectal cancer before endoscopic treatment by Kazuya Inoki, Taku Sakamoto, Hiroyuki Takamaru, Masau Sekiguchi, Masayoshi Yamada, Takeshi Nakajima, Takahisa Matsuda, Hirokazu Taniguchi, Shigeki Sekine, Yukihide Kanemitsu, Yuichiro Ohe, Yutaka Saito

Get full text

Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma. by Keisuke Kirita, Genichiro Ishii, Rie Matsuwaki, Yuki Matsumura, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Koichi Goto, Hironobu Ohmatsu, Yuichiro Ohe, Kanji Nagai, Atsushi Ochiai

Get full text

Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions by Chie Morita, Tatsuya Yoshida, Masayuki Shirasawa, Ken Masuda, Yuji Matsumoto, Yuki Shinno, Shigehiro Yagishita, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Noriko Motoi, Yasushi Yatabe, Yuichiro Ohe

Get full text

Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy by Tomohiro Tanaka, Yasushi Goto, Masafumi Horie, Ken Masuda, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Tatsuya Yoshida, Hidehito Horinouchi, Noriko Motoi, Yasushi Yatabe, Shunichi Watanabe, Noboru Yamamoto, Yuichiro Ohe

Get full text

Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non‐small cell lung cancer patients by Masahiro Torasawa, Tatsuya Yoshida, Yuki Takeyasu, Yukiko Shimoda, Akiko Tateishi, Yuji Matsumoto, Ken Masuda, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Kazuhisa Takahashi, Yuichiro Ohe

Get full text

Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations by Yuki Takeyasu, MD, Tatsuya Yoshida, MD, Ken Masuda, MD, Yuji Matsumoto, MD, Yuki Shinno, MD, Yusuke Okuma, MD, Yasushi Goto, MD, Hidehito Horinouchi, MD, Noboru Yamamoto, MD, Yuichiro Ohe, MD

Get full text

Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With Alectinib by Yuki Takeyasu, MD, Tatsuya Yoshida, MD, Ken Masuda, MD, Yuji Matsumoto, MD, Yuki Shinno, MD, Yusuke Okuma, MD, Yasushi Goto, MD, Hidehito Horinouchi, MD, Noboru Yamamoto, MD, Yuichiro Ohe, MD

Get full text

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study by Saeka Egami, Hitoshi Kawazoe, Hitoshi Kawazoe, Hironobu Hashimoto, Ryuji Uozumi, Toko Arami, Naomi Sakiyama, Yuichiro Ohe, Hideo Nakada, Tohru Aomori, Tohru Aomori, Shinnosuke Ikemura, Shinnosuke Ikemura, Koichi Fukunaga, Masakazu Yamaguchi, Tomonori Nakamura, Tomonori Nakamura

Get full text